| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Electron transport chain oxphos system in mitochondria 0.6306307106730202 4.207232795948978 2.5851679523070104e-05 0.0149587140096982 0.0150715291619504 57 Q16795,P00403,O14949,Q9UDW1,P00846,O43676,O75964,P03928,P14927,P14406,O75438,O75880,P05141,P12235,O75489,P03886,O75306,O75251,O43674,O14548,P13073,P21912,P12236,Q7KZN9,P20674,P56385,O00483,Q9Y6M9,P24539,O96000,Q15526,O75947 32 |
| Nonalcoholic fatty liver disease 0.5968360302359794 3.699136248419225 0.0002163344499572 0.1185055988488315 0.0420409947750312 49 P00403,O14949,Q9UDW1,O43676,Q86Y39,P14927,P14406,Q9NX14,O75438,Q9P0J0,Q96GC9,O75306,P08574,O14548,P13073,P21912,P20674,O00483,Q9Y6M9 19 |
| Mitochondrial complex iv assembly 0.8358994161633432 3.210415296096619 0.0013254332549077 0.5384847309947572 0.1545455175222436 13 O43819,P13073,P14406,Q7KZN9,P00403,P20674,O00483,Q9Y2R0 8 |
| Sphingolipid metabolism overview 0.8378078184865683 2.6932230820139185 0.0070764902842257 0.9840812947600428 0.2423821580901906 9 Q06136,O95470,Q13510,Q96G23,Q16880,Q16739,O15121 7 |
| Ferroptosis 0.6248864666452436 2.651409714246509 0.0080156540333236 0.9908312661063076 0.2423821580901906 21 P45880,Q96QD8,P33121,Q9NZ45,P09601,Q9Y277,P16435 7 |
| Sphingolipid metabolism integrated pathway 0.8300137445667675 2.592705403998613 0.0095224299370995 0.996220554262091 0.2423821580901906 10 Q06136,O95470,Q13510,Q96G23,Q16880,Q16739,O15121,O15269 8 |
| Oxidative phosphorylation 0.5420493443822006 2.584571990764035 0.009749994764872 0.996694405965728 0.2423821580901906 34 O95168,Q16795,P00846,O75964,Q86Y39,O75787,O75438,O75489,P03886,O75306,O75251,O43674,P56134,Q15904,P56385,O00483,Q9Y6M9,P24539,O96000,O75947 20 |
| Sphingolipid metabolism in senescence 0.7562074722252194 2.583450418362928 0.0097817525819279 0.9967556377705504 0.2423821580901906 12 Q06136,P04062,Q13510,Q96G23,Q16739,O15121 6 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5974898444483272 2.4623360215701795 0.0138035276449559 0.9996975258462212 0.2479086593788315 21 O95864,Q16850,Q15392,P33121,O00767,Q14534,Q14739,Q15800,O76062 9 |
| Sphingolipid pathway 0.7937484361161625 2.418368959640838 0.0155902597752466 0.99989491252291 0.2479086593788315 10 Q06136,O95470,P04062,Q13510,Q96G23,Q16880,Q16739,O15269 8 |
| Mitochondrial complex i assembly model oxphos system 0.537264741984308 2.377416289441931 0.0174343997161785 0.9999647802083342 0.2479086593788315 30 O95168,Q9P032,O75489,P03886,Q9NPL8,O75306,Q9NX14,P51970,O75438,O43674,Q8IUX1,Q9NW81,Q9BQ95,Q9P0J0,Q9Y6M9,O43676,O96000,Q9Y375 18 |
| Mitochondrial immune response to sarscov2 0.7621573052478274 2.2634760884686993 0.0236063569911646 0.9999991059910108 0.2652010918474609 10 Q7Z434,Q9BQ95,Q9Y6M9,Q99623,Q86UT6,Q9Y375 6 |
| Metabolism of spingolipids in er and golgi apparatus 0.903133903133902 2.2626982012761183 0.0236542997874236 0.9999991312210574 0.2652010918474609 5 O95470,Q10472,Q06136,Q16739 4 |
| Mitochondrial complex iii assembly 0.7560409505141944 2.2331580283938353 0.0255385250426074 0.9999997182882284 0.2675823918014695 10 P14927,P08574,O14949,Q9UDW1,Q9NVA1 5 |
| Oxidation by cytochrome p450 0.8786259626088087 2.1605095199457223 0.0307332474363208 0.9999999875131408 0.2756535885442319 5 Q16850,P16435,O43169 3 |
| Novel intracellular components of rigilike receptor rlr pathway 0.7097559636915204 2.0644302281630145 0.0389769428898267 0.9999999999141362 0.3293269232575219 9 Q13546,Q86UT6 2 |
| Glycerophospholipid biosynthetic pathway 0.7374678178707649 2.044926034788754 0.040862150752535 0.99999999997267 0.3355300547708162 7 O95674,O00116,Q8WUK0 3 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.8474869240270279 2.029050680175621 0.0424531285849805 0.9999999999896174 0.3437524161811616 5 Q13546 1 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8192920499973695 1.9084909675970352 0.0563277894828087 0.999999999999998 0.4021964933063142 5 Q16850,Q15392,Q14739 3 |
| G protein signaling pathways 0.6153130172517839 1.8061652035313809 0.0708925384006382 1.0 0.4380819607779521 12 Q9UBI6,P63096,P63218,O43823,P04899 5 |
| Cytosolic dnasensing pathway 0.6706793007671665 1.798899474704774 0.072034583714688 1.0 0.4380819607779521 10 Q13546,Q86UT6 2 |
| Omega3 omega6 fatty acid synthesis 0.7248463298476694 1.795650468233773 0.0725501240235382 1.0 0.4380819607779521 6 O95864,P33121,O15254 3 |
| Adipogenesis 0.5650232330164954 1.7518088964867875 0.0798066739387373 1.0 0.445599288790288 14 O00767,Q9NZ45,O75844,P43490 4 |
| Influence of laminopathies on wnt signaling 0.6367103434397601 1.749215757736431 0.0802537312572559 1.0 0.445599288790288 8 O60725,O75844 2 |
| Metapathway biotransformation phase i and ii 0.5012006716285806 1.6995838238428609 0.0892092351807924 1.0 0.4628579451266537 20 Q16850,Q8NCH0,Q7LGA3,P21964,P07099,O14880,Q6UW02 7 |
| Mitochondrial long chain fatty acid betaoxidation 0.5604981402156481 1.6507913542273582 0.0987811861476601 1.0 0.4885799909046028 13 P40939,O43772,P23786,P22307 4 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5823689993325633 1.6146824782822509 0.1063794738919881 1.0 0.5020699883382909 12 O60725,O75844,P42167 3 |
| Kennedy pathway from sphingolipids 0.8139569535435555 1.6128055698094328 0.1067867556671493 1.0 0.5020699883382909 4 O95470,Q9UG56 2 |
| Camkk2 pathway 0.6325054579077755 1.5982283340949055 0.1099921700950501 1.0 0.5053188138293938 10 P09601,Q9Y3D6 2 |
| Familial partial lipodystrophy fpld 0.6715997062991672 1.5425568205031148 0.1229383415215794 1.0 0.5156334755905095 6 O60725,O75844,P20700 3 |
| Ccl18 signaling pathway 0.6205608411741577 1.53469301801343 0.1248592516832276 1.0 0.5159946466220725 10 Q96GC9,P07196,Q86UE4,P00403 4 |
| 7oxoc and 7betahc pathways 0.595839979724983 1.530155482502592 0.1259782476089346 1.0 0.5159946466220725 8 O15118,P34913,P22307,Q9UBM7,O14734 5 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.936239373733144 1.5169925449853543 0.1292685662609876 1.0 0.5159946466220725 3 P09601 1 |
| Ppar signaling pathway 0.5048092923236737 1.515707284066074 0.1295933849776716 1.0 0.5159946466220725 16 O95864,P22307,P33121,O00767,P23786,Q13418,O15254 7 |
| Proteoglycan biosynthesis 0.7844505149548932 1.4897675670626334 0.1362853617036354 1.0 0.5296957724881299 4 Q8TB61 1 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.5774716661338118 1.4303856320775667 0.1526063696721153 1.0 0.5359609248123088 8 P31943,P51148,P20339 3 |
| Fatty acid betaoxidation 0.4700673373288957 1.4126411909004517 0.1577612512359398 1.0 0.5465051803592281 19 P55084,O95573,P35610,O43772,P43304,P40939,P33121,P50416,P23786,P09622,Q16836 11 |
| Nephrotic syndrome 0.546230326431524 1.4009364113763267 0.1612330892311959 1.0 0.5465051803592281 12 Q96D53,Q9BT22,Q14108 3 |
| Glycerolipids and glycerophospholipids 0.7583347011388761 1.3802882796855271 0.1674979021571072 1.0 0.5541363502562353 4 Q9UG56 1 |
| S1p receptor signal transduction 0.6378899435509477 1.3797641728339127 0.1676592670222341 1.0 0.5541363502562353 6 Q13510,P63096 2 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.5939509467269541 1.3270080114770872 0.1845060325213765 1.0 0.5639193954109036 7 Q15118 1 |
| Cholesterol biosynthesis pathway 0.5817749936888289 1.3262741897780108 0.1847488928361622 1.0 0.5639193954109036 10 Q16850,P48449,Q15800,Q14534 4 |
| Statin inhibition of cholesterol production 0.7320385015119275 1.269720846881027 0.2041840842611191 1.0 0.598084535475241 4 Q8WTV0 1 |
| Urea cycle and related diseases 0.8363571682675228 1.264008215655496 0.2062270781554314 1.0 0.598084535475241 2 Q9Y619 1 |
| Copper homeostasis 0.5412855228575917 1.231945346420099 0.2179695006537876 1.0 0.6096032792851408 8 O43819 1 |
| Endothelin pathways 0.5393151972465335 1.2210842665778152 0.2220541160902778 1.0 0.612222203376656 8 P16615,P63096,P00403 3 |
| Envelope proteins and their potential roles in edmd physiopathology 0.4540407637539058 1.203145851913466 0.2289198844962858 1.0 0.6130444055100526 17 P42167,O94901,Q14739 3 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.7145561487451191 1.196159308775675 0.2316343967098784 1.0 0.6130444055100526 4 Q9BXK5 1 |
| Oxysterols derived from cholesterol 0.5682635346808055 1.1944891391281347 0.2322866866670232 1.0 0.6130444055100526 7 Q9UBM7,P34913,P22307,O14734 4 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.849766038045346 1.1824380480695202 0.2370319336721005 1.0 0.6141853318589772 3 Q15382 1 |
| Nad metabolism 0.8471335508927255 1.172291893606728 0.241079885086703 1.0 0.6141853318589772 3 Q8IXJ6 1 |
| Nad biosynthetic pathways 0.8471335508927255 1.172291893606728 0.241079885086703 1.0 0.6141853318589772 3 Q8IXJ6 1 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.5532210569299307 1.171231757879815 0.2415056332476002 1.0 0.6141853318589772 10 Q13546,Q7Z434 2 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.4773621353017307 1.1271270647919462 0.2596887618280794 1.0 0.6232068174447973 13 O43819,Q8IXJ6 2 |
| Omega9 fatty acid synthesis 0.583460984921852 1.1142744277919625 0.2651614740647505 1.0 0.6309760791010186 6 P33121,O00767 2 |
| Ketogenesis and ketolysis 0.5820058320520661 1.1071571946904706 0.2682259708486296 1.0 0.6318758629707825 6 P53985,O43772,P23786 3 |
| Vitamin d metabolism 0.8234875444839871 1.081441414060912 0.2795008079823855 1.0 0.6363705862171446 3 P38435,P04062 2 |
| Vitamin d receptor pathway 0.5325102546845923 1.0583048629687055 0.2899164766176136 1.0 0.6496151736041262 10 Q96KA5,Q5VV42 2 |
| Cellular proteostasis 0.6752392832835846 1.0311503988328148 0.3024702966323251 1.0 0.656431771410194 4 P61758 1 |
| Autosomal recessive osteopetrosis pathways 0.7783706865884061 1.0209507326565102 0.3072777811899687 1.0 0.6586137736534992 2 P51798 1 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.6659273415745112 0.9922710285670526 0.3210653319586443 1.0 0.6781923497532233 4 O60725,P20700 2 |
| Progeriaassociated lipodystrophy 0.5023428391164999 0.9548510827975314 0.3396530103336705 1.0 0.6908705271642531 9 O60725,O75844,P20700 3 |
| Pkcgamma calcium signaling pathway in ataxia 0.762006403415159 0.9536016704793868 0.3402853098669038 1.0 0.6908705271642531 2 Q15118 1 |
| Inclusion body myositis 0.769750889679718 0.8780715611799506 0.37990488503552 1.0 0.733392542965921 3 Q92542,P49768 2 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.4977187370551764 0.8687329577416545 0.3849932102828035 1.0 0.7359050544094244 10 P07196,P51149,Q9NR77,O95140,Q8TB36,Q15907 6 |
| Tryptophan metabolism 0.417558429065143 0.8477737603931932 0.3965639789606374 1.0 0.7383317153784155 15 P05091,Q15392,P40939,P51648,Q16836 5 |
| Zinc homeostasis 0.7604982206405683 0.8436959044508648 0.3988393567335504 1.0 0.7383317153784155 3 Q8NEW0,Q8TAD4 2 |
| Arachidonate epoxygenase epoxide hydrolase 0.7260761294912912 0.808798613682524 0.4186309937698089 1.0 0.7532135987020631 2 P20674 1 |
| Purinergic signaling 0.7344693150506445 0.748407793320705 0.4542142232030248 1.0 0.79012609325953 3 P63096 1 |
| Nuclear receptors in lipid metabolism and toxicity 0.7072216293134178 0.7350030465203135 0.4623376387310149 1.0 0.7974640336691767 2 P08183 1 |
| Apoptosis 0.4591775120624949 0.7197048118806912 0.4717067629403941 1.0 0.7993625617847122 9 Q13546 1 |
| Degradation pathway of sphingolipids including diseases 0.4891675396837321 0.6586517404179217 0.5101194295470615 1.0 0.8330521776636886 6 P17900,O43681,P06865 3 |
| Thermogenesis 0.3441730340349953 0.6341275035947234 0.5259976148380783 1.0 0.8452744560150062 24 Q15418,O43772,P33121,P23786,Q15382 5 |
| Amyotrophic lateral sclerosis als 0.4176185417371131 0.6292235640946353 0.5292027040231171 1.0 0.8452744560150062 12 Q9BUN8,O96008,P20339 3 |
| Gastric cancer network 2 0.4097372659279713 0.5832274562375965 0.5597401903651802 1.0 0.8540549535776368 12 Q86UE4 1 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.6865767981993995 0.580304570021083 0.5617092461351554 1.0 0.8540549535776368 3 Q15758 1 |
| Glycosylation and related congenital defects 0.4476150902977763 0.5779351547367323 0.5633078997649594 1.0 0.8540549535776368 7 Q9BT22 1 |
| Tlr4 signaling and tolerance 0.6800209735052004 0.558214837068017 0.5766976904879673 1.0 0.8540549535776368 3 Q13546 1 |
| Oligodendrocyte specification and differentiation leading to myelin components for cns 0.6570615439345509 0.5489457776342105 0.5830426612759854 1.0 0.8540549535776368 2 P09543 1 |
| Joubert syndrome 0.3719070986722547 0.5441832027751716 0.5863154095162417 1.0 0.8550953061227158 15 O43924,Q15382 2 |
| Oxidative stress response 0.5017962611715733 0.5142307289168137 0.6070906860119745 1.0 0.859062791128595 5 P09601 1 |
| Eicosanoid metabolism via lipooxygenases lox 0.4552557528802459 0.5027122468496004 0.6151665980052405 1.0 0.8641978955109765 6 O15254 1 |
| Sarscov2 and covid19 pathway 0.6435425145767921 0.4404277525871332 0.6596273282178011 1.0 0.8993559915287258 3 Q8WTV0 1 |
| Vitamin b12 disorders 0.6377224199288247 0.4225355591322526 0.6726341514033529 1.0 0.8993559915287258 3 Q99707,P22033 2 |
| Mitochondrial gene expression 0.5198470705891622 0.4192376405944945 0.6750424656807947 1.0 0.8993559915287258 4 O00411,Q9P2K5 2 |
| Egfegfr signaling pathway 0.3046661839971651 0.4061188165433723 0.6846553007003227 1.0 0.8993559915287258 35 P30086,Q15418,P00403,P51812,Q9P0J0 5 |
| Bdnftrkb signaling 0.4097966658595269 0.3981137655670463 0.6905463278298758 1.0 0.8993559915287258 7 Q15382 1 |
| Pparalpha pathway 0.4085834167196779 0.3925709884930203 0.6946363705779603 1.0 0.8993559915287258 7 P23786 1 |
| Glycosaminoglycan degradation 0.4298327067124325 0.3915863773834775 0.6953638549498888 1.0 0.8993559915287258 6 P54802,P15586 2 |
| Angiopoietinlike protein 8 regulatory pathway 0.3123912693405674 0.3784285300100686 0.7051122774038387 1.0 0.9034735334646988 24 Q15418,O75955,O00767,P51812,Q14254,P18031,Q15382,O14654 8 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.3801103758273633 0.3660391829733312 0.7143358376727771 1.0 0.909296492059452 8 Q15418 1 |
| Tca cycle aka krebs or citric acid cycle 0.3342126741720428 0.3459277265094976 0.7293970308303301 1.0 0.9185741952595352 16 P21912 1 |
| Eicosanoid metabolism via cyclooxygenases cox 0.4188674013703382 0.3456737524187964 0.7295879121412288 1.0 0.9185741952595352 6 O15254 1 |
| Valproic acid pathway 0.4493061051013389 0.3135527651039093 0.7538607394130574 1.0 0.933087527656796 5 P40939 1 |
| Chemokine signaling pathway 0.3284281084339347 0.3099166048139932 0.7566243752708117 1.0 0.933087527656796 16 P04899,P63096,P63218 3 |
| Nocgmppkg mediated neuroprotection 0.4862333847327678 0.3072753844308413 0.7586337703418891 1.0 0.933087527656796 4 P30536 1 |
| Vasopressinregulated water reabsorption 0.3293684774438607 0.2800043320857352 0.779474181259729 1.0 0.9384816021445144 15 Q12846,Q15907,P51148,P20339 4 |
| Heme biosynthesis 0.4394586894587032 0.2791386942009178 0.7801383891427689 1.0 0.9384816021445144 5 P22830,P06132,P08397,P36551 4 |
| Tp53 network 0.5521166844539428 0.2347717618394513 0.8143858860149522 1.0 0.9630567374172762 2 Q07812 1 |
| Mammary gland development pathway involution stage 4 of 4 0.5521166844539428 0.2347717618394513 0.8143858860149522 1.0 0.9630567374172762 2 Q07812 1 |
| Pilocytic astrocytoma 0.5410885805763196 0.2096030039980034 0.8339775348736713 1.0 0.9681113318137136 2 P62993 1 |
| Urea cycle and metabolism of amino groups 0.3436720142602463 0.1989459519470712 0.8423050234466636 1.0 0.9681113318137136 8 P12277,P52788,P54886,P00367,P32322,P19623,P78540 7 |
| Cancer immunotherapy by pd1 blockade 0.5261472785485717 0.1782170924890088 0.8585524867369625 1.0 0.9732880770299944 2 Q06124 1 |
| Spinal cord injury 0.2994973622870326 0.1652826586632223 0.8687215074762291 1.0 0.9758470883596178 18 Q9NQC3,Q08722 2 |
| Thyroid stimulating hormone tsh signaling pathway 0.3003866116414628 0.146101502569784 0.883841260267276 1.0 0.9871253922142184 16 Q15418,P63096 2 |
| Calcium regulation in cardiac cells 0.2804468451007905 0.1398332796601104 0.8887917182459026 1.0 0.9905128753800788 25 Q9UBI6,Q9Y3B8,P16615,P63096,P54709,P63218,P04899 7 |
| G1 to s cell cycle control 0.2805486183923381 0.122690724236763 0.9023520093563548 1.0 0.9925872102919904 22 Q14566 1 |
| Steroid biosynthesis 0.4706510138740757 0.0891721792882047 0.9289450749887675 1.0 1.0 2 P51659 1 |
| Sleep regulation 0.3880213853040722 0.0617681680740321 0.9507474532618532 1.0 1.0 4 Q99808 1 |
| Serotonin htr1 group and fos pathway 0.3170727147892877 0.0536459206288141 0.9572172697919004 1.0 1.0 9 P63096 1 |
| Amino acid metabolism pathway excerpt histidine catabolism extension 0.424404126645331 0.0455123896886869 0.963698899589034 1.0 1.0 2 Q8TD30 1 |
| Biomarkers for pyrimidine metabolism disorders 0.3296244683785634 0.0393415227418872 0.9686181018649576 1.0 1.0 6 Q9H0P0 1 |
| 1q211 copy number variation syndrome 0.3443732193732167 0.0216892914500162 0.9826958059498774 1.0 1.0 5 P54619,Q9NPH0,Q07157,P55196 4 |
| Fibrin complement receptor 3 signaling pathway 0.3475631447883424 0.0158135480591799 0.9873831400003844 1.0 1.0 2 Q04864 1 |
| Ciliopathies 0.2811805172244041 0.0132571704396071 0.9894226182208814 1.0 1.0 14 Q10713,O43924,Q13432 3 |
|
|
